Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-12-18

Clinical Trial Update: Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children [Phase 4]

View source ↗

Summary

Phase 4 trial of pimecrolimus for atopic dermatitis in African American children was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimecrolimus (pimecrolimus)

Snippet

Sponsor: Children's Hospital of Michigan | Conditions: Atopic Dermatitis | Phase 4 | Status: TERMINATED